ADVIK LABORATORIES LIMITED

ALL/BS E/O UT-B M/Q3/l_6 17 / 283

Dated: 14th February, 2Ot7

The Manager (Listing)

BSE Limited
Floor L, P.J.Towers
Dalal Street, Fort
Mumbai - 400001

Sub: Outcome of Board Meeting and Submission of Unaudited Financial Results and Limited Review Report for the
quarter & nine months ended 31't Decemb er,2OL6 as required u/r 33 of the SEBI (LODR) Regulations, 2015.

Ref: Scrip Code 531586

Dear Sir,

This is to inform you that in pursuance

to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of
the Company in their meeting held on Tuesday 14th February,2OLT at 807, Arunachal Building, 19, Barakhamba
Road, Connaught Place, New Delhi - 110001 and concluded just now has, inter-alia, transacted the following
businesses:

1. Considered and Approved the Unaudited Financial Results of the Company for the quarter & nine months
ended 31st December, 201"5,

2. Considered and taken on record Limited Review Report submitted by the Statutory Auditors of the company
for the quarter & nine months ended 31st December, 201G.

Fufther, pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, a copy of the aforesaid Financial Results
alongwith Limited Review Report are enclosed herewith for your kind perusal.

Kindly take the aforesaid information in your records.

Thanking you.

Yours Truly,
FoT ADVIK LABORA

(Pooja Chuni)
Company Secretary
Mem. No. A16272

Encl: As stated above.

CIN No.: t74899HR1994PtC038300

.|000.l
Corporole Office : 807, Aunochol Building,l9, Borokhombo Rood, Connought Ploce, New Delhi - I
Phones :Ol1-42424884,0.l I 43571043-45 Fox:0.l 1-43571047
.l38,
Regd. Office & Foctory : Roz-Ko Meo, Industriol Areo, Sohno - 122103 (Distt. Mewot), Horyono
Piones : 0124-2362471 E-moil : moil@odvikindio,com Websife : www.odMkindio.com
 ADVIK LABORATORIES LIMITED
r 138. Roz Ka Meo lndustrial Area, Sohna, Distt. Mewat Haryana '122103
AIoTIe IITIIT,Io|TEo TINANGIAL RESULTS FoR THE QUARTER & NINE MONTH ENDED DECEMBER 31, 2016
CIN : L74899HR1994PLC038300

Year to date
figures for the
current period
ended
31.12.2015

a. Net Sales/ Income from operation (Net of excise duty) (1 e3.61 )

Purchase of Stock in Trade

inventories of finished goods, work in progress (1 4.81)

expenses(Any item exceeding 1 0% of the total

relating to continuing operations to be shown

from operations before other income,

Profiu(Loss) from ordinary activities before finance costs

ProfiU(Loss) from ordinary activities after finance costa

Profiuloss from Ordinary Activies after Tax (9-10)

Net Profit / (Loss) afler taxes but before share of profit i

(loss) of associates and minority interest (1 1+12)
Share of ProfiV(Loss) of Associates

Net Profit / (Loss) after taxes, minority interest and share

of associatea (13 + 14 + 1 5)
up Equity Share Capital (Rs. 10/- per share) 1,911.14 '1.91'r.14
excluding revaluation reseryes as per balance sheet

per share (before extra ordinary items) of Rs. 1 0/- per

Earning per share (after extra ordinary items) of Rs. 10/- per

Notes :

1 Theabovefinancial results havebeenreviewedbytheAuditCommittee&approvebytheBoardof DirectorsinthemeetingheldonFebruaryl4'20'17

2 TheStatutoryAuditorshavecarriedoutthe"LimitedReview"oftheStandalonefinancial resultsoftheCompanyforthequarter&ninemonthsendedDecember3l,
2016 in accordance with regulation33 of the SEBI (LODR) Regulations, 2015.
3 Thestatementofunauditedfinancial resultsforthequarterandninemonthended3lstDecember,20l6hasbeenpreparedfollowingthesameaccountingpoliciesas
were followed in the annual financial statement for the year ended 31st March, 2016.
4 TheCompanyisengagedinpharmaceuiicalsbusinessonly&therefore,thereisonlyonereportablesegmentasperAS-lTissuedbythelCAl.
5 No investor complaint was pending as on 31 st December, 201 6 and no complaint was received during the quarter under review.
6 previous yearlperiod figures have been regrouped/rearranged, wherever necessary to make them comparable with the current Period figure.

Place: New Delhi

Date : 14th February, 2017 For and
 RMA & Associates (Boe00r:2008 Firm)
Chartered Accountants

Limited Review Report to

The Board of Directors

Advik La boratories Limited

We have reviewed the accompanying statement of unaudited financial results of M/s. Advik
Laboratories Limited for the quarter and nine months ended 3l-'t Decemb er, 20L6. This statement is the
responsibility of the Company's Management and has been approved by the Board of Directors. Our
responsibility is to issue a report on these financial statements based on our review.

We conducted our review in accordance with the Standard on Review Engagement (SRE) 2400,
Engagements to Review Financial Statements issued by the lnstitute of Chartered Accountants of India.
This standard requires that we plan and perform the review to obtain moderate assurance as to
whether the financial statements are free of material misstatement. A review is limited primarily to
inquiries of company personnel and analytical procedures applied to financial data and thus provide less
assurance than an audit. We have not performed an audit and accordingly, we do not express an audit
opinion.

Based on our review conducted as above, nothing has come to our attention that causes us to believe
that the accompanying statement of unaudited financial results prepared in accordance with applicable
accounting standards and other recognized accounting practices and policies has not disclosed the
information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 201"5 including the manner in which it is to be disclosed, or that it
contains any material misstatement.

For M/s. RMA & Associates

Chartered Accou
FRN:000978N

(Membership No.: 533944)

Place: New Delhi

Date:14h February,2oL7

48, UG-z, Hasanpur, l.P. Extension, Delhi-110 092

Tel : 011-45261214,43465985 Fax : 011-22248165 E-mail i rma.ca12@gmail.com
Branches:. NewDelhi o Faridabad o Kanpur oAhmedabad